Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation

被引:0
|
作者
Colunga-Pedraza, Perla R. [1 ]
Irabien-Zuniga, Mariela [1 ]
Rodriguez-Roque, Carlos Saul [1 ]
Cruz, Carlos de la Cruz-de la [1 ]
Leon, Andres Gomez-De [1 ]
Santana-Hernandez, Paola [1 ]
Jaime-Perez, Jose Carlos [1 ]
Mancias-Guerra, Consuelo [1 ]
Gomez-Almaguer, David [1 ]
机构
[1] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Francisco I Madero Ave, Mitras Ctr, Monterrey, Nuevo Leon, Mexico
关键词
Stem cells; Autologous transplantation; Hematopoietic stem cell mobilization; Lactate dehydrogenase; COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD; G-CSF; YIELD; ISOENZYMES; AGE;
D O I
10.1016/j.htct.2022.07.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Pre-apheresis peripheral blood CD34+ cell count (PBCD34+) is the most important predictor of good cell mobilization before hematopoietic stem cell transplantation, albeit flow cytometry is not always immediately available. Identification of surrogate markers can be useful. The CD34+ cells proliferate after mobilization, resulting in elevated lactate dehydrogenase (LDH) activity and correlating with the PBCD34+ count.Objective: To determine the LDH cut-off value at which adequate CD34+ cell mobilization is achieved and its diagnostic yield. Materials and methods: A total of 103 patients who received an autologous stem cell transplantation (ASCT) between January 2015 and January 2020 were included. Demographic and laboratory characteristics were obtained, including complete blood count, pre-apheresis PBCD34+ and LDH levels. Receiver operating characteristic (ROC) curves were performed to identify the optimal serum LDH activity cut-off points for > 2 and >= 4 x 10(6) cells/kg post mobilization CD34+ count and their diagnostic yield.Results: A post-mobilization serum LDH cut-off value of 462 U/L yielded a sensitivity (Se) = 86.8% (positive predictive value [PPV] = 72.7%), a pre-and post-mobilization serum LDH difference cut-off value of 387 U/L, an Se = 45.7% (PPV = 97%) and an LDH ratio of 2.46, with an Se = 47.1% (PPV = 97%) for an optimal mobilization count (CD34+ >= 4 x 10(6)).Conclusion: The LDH measurement represents a fast and affordable way to predict PBCD34+ mobilization in cases where flow cytometry is not immediately available. According to the LDH diagnostic yield, it could be used as a surrogate marker in transplant centers, supporting the CD34+ count, which remains the gold standard.(c) 2022 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [41] Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
    Milanetti, Francesca
    Bucha, Jurate
    Testori, Alessandro
    Burt, Richard K.
    CURRENT STEM CELL RESEARCH & THERAPY, 2011, 6 (01) : 16 - 28
  • [42] Autologous hematopoietic stem cell transplantation for autoimmune disease
    Passweg, JR
    Gratwohl, A
    Tyndall, A
    NEW CONCEPTS IN PATHOLOGY AND TREATMENT OF AUTOIMMUNE DISORDERS, 2001, (S7): : 123 - 132
  • [43] Application of autologous hematopoietic stem cell transplantation for pemphigus
    Wang, Menglei
    Cao, Can
    Sun, Jing
    Peng, Xuebiao
    Liu, Qifa
    Huang, Liang
    Chai, Yanyan
    Lai, Kuan
    Chen, Pingjiao
    Liu, Qingxiu
    Li, Qian
    Peng, Yusheng
    Xiong, Hao
    Zhang, Jing
    Chen, Minghua
    Zeng, Kang
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (03) : 296 - 301
  • [44] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SYSTEMIC SCLEROSIS
    Nitsche, Alejandro
    Milovic, Vera
    Requejo, Alejandro
    Real, Juan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S23 - S23
  • [45] The Relationship Between Serum Lactate Dehydrogenase Enzyme Levels and Myeloid Engraftment in Hematopoietic Stem Cell Transplantation
    Bolat, Ahmet
    Gursel, Orhan
    Zeybek, Cengiz
    Kurekci, Ahmet Emin
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (07) : 1665 - 1670
  • [46] Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
    Jantunen, Esa
    Partanen, Anu
    Turunen, Antti
    Varmavuo, Ville
    Silvennoinen, Raija
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05) : 438 - 447
  • [48] Toward a More Rational Policy for Autologous Hematopoietic Stem Cell Mobilization
    Devine, Steven M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (10) : 1468 - 1470
  • [49] Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    Uy, GL
    Fisher, NM
    Devine, SM
    Adkins, DR
    Tomasson, MH
    Graubert, TA
    DiPersio, JF
    Vij, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 77 - 77
  • [50] Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation
    Martin-Sanchez, Guillermo
    Amunarriz, Cristina
    Sanchez, Miriam
    Bermudez, Maria Aranzazu
    Yanez, Lucrecia
    Colorado, Mercedes
    Richard, Carlos
    Conde, Eulogio
    Arroyo, Jose Luis
    BLOOD, 2016, 128 (22)